Tehran University of Medical Sciences

Science Communicator Platform

Share By
Personalized Cancer Therapies Publisher



F Khatami FATEMEH ; Gp Patrinos George P ; S Nikfar SHEKOUFEH ; Hr Aghaei Meybodi Hamidreza REZA ; Ba Larijani Bagher A ; M Nosrati MARZIYEH ; M Hasanzad MANDANA ; N Sarhangi NEGAR
Authors

Source: Published:2024


Abstract

The emergence of personalized cancer treatment introduced a paradigm shift in oncology, where therapeutic approaches are customized to the distinct molecular and genetic properties of individual malignancies. This strategy, which is based on the complex field of molecular biology, targets certain molecules involved in the development and spread of cancer to maximize therapeutic success and minimize side effects. The U.S. Food and Drug Administration’s (FDA) approval of personalized drugs designed to target specific genetic alterations and biomarkers in cancer is highlighted as a recent milestone in cancer treatment. A future is envisioned where precision medicine seamlessly integrates into mainstream cancer care by emphasizing ongoing research, technological advancements, and global collaboration. Innovations in clinical trial design are highlighted as essential for validating the effectiveness of personalized treatments. The narrative anticipates a dynamic journey toward unlocking the full potential of precision oncology, offering a glimpse into a future where cancer care is truly personalized, effective, and ethically guided. This review provides a comprehensive overview of the molecular underpinnings and insight into the foundation of this groundbreaking approach. © 2025 Elsevier B.V., All rights reserved.
Other Related Docs
4. Circulating Tumor Dna (Ctdna) in the Era of Personalized Cancer Therapy, Journal of Diabetes and Metabolic Disorders (2018)
8. Breast Cancer in the Era of Precision Medicine, Molecular Biology Reports (2022)
10. Personalized Medicine in Breast Cancer: Pharmacogenomics Approaches, Pharmacogenomics and Personalized Medicine (2019)
13. Liquid Biopsy in Bladder Tumors, Liquid Biopsy in Urogenital Cancers and its Clinical Utility (2022)
14. Immunogenicity of Neoantigens: From Car-T Cell to Various Vaccines, International Journal of Pharmaceutics (2025)
17. Commercial and Regulatory Challenges in Cancer Nanomedicine, Functionalized Nanomaterials for Cancer Research: Applications in Treatments# Tools and Devices (2024)
18. Targeted Cancer Therapy: Review Article, Tehran University Medical Journal (2018)
19. Horizon of Cancer Genetics and Psycho-Art, Cancer Genetics and Psychotherapy (2017)